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Accepted 10 March 2011AbstractObjective: Mesenchymal stem cells (MSCs) are an attractive source for providing the cells necessary for regenerating damaged tissues. Fetal
MSCs (fMSCs) are known to proliferate fast and have an excellent osteogenic capacity, yet the underlying mechanisms need to be explored. A
better understanding of MSCs from different anatomic origins and ages will eventually benefit cell-based therapies, as well as subsequent
mechanistic studies in the field of stem cell biology.
Materials and Methods: We identified the molecular signatures of fetal and adult MSCs via a meta-analytic strategy and compared the enriched
canonical pathways and genetic networks within each signature.
Results: Fetal MSCs were found to express more cell cycle genes, which is consistent with the results of wetlab functional assays. In addition, the
genes involved in vasculogenesis, neurogenesis, Wnt, MAPKKK pathways, and RNA splicing were found to be enriched in fMSCs. Correlating
with the overexpression of multilineage differentiation genes, fMSCs share more genes with embryonic stem cells (ESCs) and are, therefore,
more primitive. Further exploration into the transcriptome similarities revealed that MSCs from umbilical cord blood (UCB) express dominant
fMSC genes, but not adult genes, suggesting a fetal origin for UCB MSCs. Novel surface proteins that were dominantly expressed in fetal and
UCB MSCs, but not in adult MSCs or maternal PBMCs, were also identified.
Conclusion: Our results systematically revealed the underlying genes and regulatory networks of two MSCs from unique origins, the resulting
phenotypes, as well as the origin of UCB MSCs. The novel membrane proteins on the fetal MSC surface are promising candidate biomarkers for
positively isolating fetal MSCs from maternal blood for noninvasive prenatal diagnosis.
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Stem cells have drawn immense research interest because
they hold great promise for future therapeutic applications.
Mesenchymal stem cells (MSC) are an attractive source of
somatic stem cells for the regeneration of damaged tissues.
Bone marrow (BM) is the primary source of multipotentcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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procedure. The number, differentiation potential, frequency,
and proliferative potential of MSCs decline with increasing
age [1]. Alternative sources from which MSCs could be iso-
lated are, therefore, the subject of intensive investigations.
MSCs have also been isolated from a variety of tissues,
including BM, umbilical cord blood (UCB) [2e4], adipose
tissue, and muscle [5e8].
Although the MSCs of different origins share common
characteristics, discrepancies in terms of gene expression
patterns, differentiation potentials, and proliferation rates exist
among them. A comparative analysis of MSCs derived from
BM, UCB, and adipose tissue has been conducted [8,9]. Gene
expression profiles and comparisons of various human MSCs
have also been reported in quite a few studies [7,10e14].
Recently, using systems biology tools, we have also shown
that perinatal MSCs isolated from Wharton’s jelly matrix of
the umbilical cord express more pluripotency markers and,
thereby, are able to grow faster than adult MSCs [15].
Regarding MSCs obtained from fetuses, these stem cells
possess a superior osteogenic capacity, proliferate faster, and
have longer telomeres compared with perinatal and adult
MSCs [16e18]. However, the underlying mechanisms have
not yet been studied. Further study of the differences in the
gene expression profiles of human fetal and adult MSCs
should provide more clues.
In this study, we closely examined the transcriptomes of
fetal and adult MSCs and applied systems biology tools to
provide insights into their differential biological activities and
responsible genes. We further compared the relationships
between UCB, fetal, and adult MSCs using a molecular
fingerprinting approach. Novel surface biomarkers that are
dominantly expressed in fetal and UCB MSCs, but not adult
MSCs or maternal PBMCs, were also identified.
Materials and methodsMicroarray data setsAll array data were gathered using the AffymetrixTM HG-
U133 Plus 2.0 GeneChip system (Affymetrix, Santa Clara,
CA, USA). Array data for embryonic stem cells (ESC) and
adult MSCs were obtained from our previous study [15]. Adult
MSC array data were also downloaded from the Gene
Expression Omnibus database (GEO; http://www.ncbi.nlm.
nih.gov/geo/; datasets GSE9451, GSE10315, GSE12274, and
GSE12843). UCB MSC array data were downloaded from
GEO dataset GSE13491. Fetal MSC array data were obtained
from datasets GSE13975 and GSE18934. Maternal peripheral
blood mononuclear cell (PBMC) array data were also obtained
from GSE18934.Array data processingFeature selection was performed as previously described
[19]. Briefly, the default robust multichip average (RMA)
settings were used to correct for background noise andnormalize and summarize all expression values using the
‘affy’ package of the Bioconductor suite of software (www.
bioconductor.org/) for the R statistical programming
language. t-Statistics were calculated as normal for each gene,
and a p-value was then calculated using a modified permuta-
tion test in the “LIMMA” package [19]. To control for
multiple testing errors, a false discovery rate (FDR) algorithm
was then applied to the p-values to calculate a set of q-values;
i.e., thresholds for the expected proportion of false positives or
false rejections of the null hypothesis [19,20]. Gene annota-
tions were performed using the ArrayFusion web tool (http://
microarray.ym.edu.tw/tools/arrayfusion/) [21].
Heat maps were created using dChip software (http://www.
dchip.org/). Principle component analysis (PCA) was per-
formed using Partek Genomics Suite (Partek, St. Louis, Mis-
souri, USA) in order to provide a visual impression of how the
various sample groups are related. Gene enrichment analysis
was performed using the Gene Ontology (GO) and KEGG
databases and DAVID Bioinformatics Resources 6.7 (http://
david.abcc.ncifcrf.gov/) [22]. The Euclidean distance between
the two groups of samples was calculated by average linkage
measurements (the mean of all pair-wise distances [i.e., link-
ages] between members of the two concerned groups) [23].
The standard error of the average linkage distance between two
groups (the standard deviation of pair-wise linkages divided by
the square root of the number of linkages) is quoted when
intergroup distances are compared in the text.Genetic network analysisDifferential gene expression profiles were imported into
the Ingenuity Pathways Analysis (IPA) software (Ingenuity
Systems, Redwood City, CA, USA, http://www.ingenuity.com/)
in order to determine any functional regulatory networks and
canonical pathways. IPA uses a curated database to construct
functional regulatory networks from a list of individual genes
and determine a statistical score for each network according to
the best fit of the network to the set of focused genes. The
score is the negative log of p and denotes the likelihood of the
focused genes in the network being found together due to
chance. The biological functions assigned to each network are
ranked according to the significance of that biological function
to the network. The Fisher’s exact test was used to calculate
p-values in order to determine the probability that the bio-
logical function assigned to a network is explained by chance
alone. The significance of the p-value calculations were based
on the hypergeometric distribution calculated using the right-
tailed Fisher’s exact test for 2x2 contingency tables. “Right-
tailed” refers to the fact that IPA only shows overrepresented
functional pathway annotations.
ResultsIncreased embryonic stem cell traits in fetal MSCsIt is well known that fetal MSCs possess a superior oste-
ogenic capacity, grow faster, and have longer telomeres
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suggested that fetal MSCs are more primitive than adult MSCs
[16e18]. To analyze whether this hypothesis could be verified
at the genomic level, we analyzed the gene expression profiles
of fetal and adult MSCs and then compared both tran-
scriptomes to that of ESCs. To eliminate the effects of indi-
vidual differences and batch effects, our own array data, as
well data obtained from four additional adult MSC array
datasets from the public data repository, were also used. Also,
two fetal MSC array datasets that had been implemented by
two different groups, GSE13975 and GSE18934 [24,25], were
included in our panel.
Genes that were differentially expressed in fetal and adult
MSCs were first filtered to determine the molecular signature
of each type of MSC according to the statistical pipeline used
[19,23]. There were 1909 probe sets that were abundantly
overexpressed in fetal MSCs and another 276 probe sets that
were overexpressed in adult MSCs (with a positive falseFig. 1. Distinct gene expression patterns and ESC traits in fetal MSCs. (A) A princi
adult and fetal MSCs. Each spot represents a single array. (B) Comparison of the tra
above. (C) Relationships between ESCs and two different types of MSCs. Average
distinguish these two types of MSC. The confidence limits shown represent the stan
different MSC groups.discovery rate (pFDR) threshold of q < 0.0001. A principle
component analysis (PCA) plot using these genes illustrates
their grouping power (Fig. 1A). The top 50 known genes most
strongly expressed in each MSC are listed in Tables 1 and 2. In
the fetal MSCs, known stem cells and proliferating genes, such
as S100A4, CDK6, and SOX11, are present (Table 1, labeled
by the asterisks). In the adult MSCs, immune response-
associated genes, including HLA-B, HLA-C, and MR1, are
present (Table 2). These probe sets were used to compare the
relationships between different MSCs and ESCs. As shown in
Fig. 1B, fetal MSCs and ESCs share a close relationship, and
this impression was verified by average linkage distance
analysis (Fig. 1C). Unsupervised hierarchical clustering was
also able to group the fetal MSCs and ESCs into the same leaf
(Fig. 1D).
It has been suggested that fetal MSCs are more primitive
than adult MSCs [16]. One of the possible mechanisms is that
fetal stem cells express more ESC genes and are, therefore,pal component analysis (PCA) plot of genes that are differentially expressed in
nscriptome traits between ESCs and different MSCs using the same gene set as
linkage distances between MSCs and ESCs were calculated using genes that
dard error. (D) A heat map showing the genes that are expressed in ESCs and
Table 1
Top 50 known genes in fetal MSCs.
Probe Set ID UniGene ID Gene Title Gene Symbol Location
202274_at Hs.516105 actin, gamma 2, smooth muscle, enteric ACTG2 chr2p13.1
227198_at Hs.444414 AF4/FMR2 family, member 3 AFF3 chr2q11.2-q12
208016_s_at Hs.709185 angiotensin II receptor, type 1 AGTR1 chr3q21-q25
209369_at Hs.480042 annexin A3 ANXA3 chr4q13-q22
219087_at Hs.435655 asporin ASPN chr9q22
222891_s_at Hs.370549 B-cell CLL/lymphoma 11A (zinc finger protein) BCL11A chr2p16.1
209030_s_at Hs.370510 cell adhesion molecule 1 CADM1 chr11q23.2
208650_s_at Hs.694721 CD24 molecule CD24 chr6q21
235287_at Hs.119882 cyclin-dependent kinase 6 *CDK6 chr7q21-q22
229831_at Hs.12723 contactin 3 (plasmacytoma associated) CNTN3 chr3p26
213110_s_at Hs.369089 collagen, type IV, alpha 5 (Alport syndrome) COL4A5 chrXq22
201116_s_at Hs.712551 carboxypeptidase E *CPE chr4q32.3
222101_s_at Hs.199850 dachsous 1 (Drosophila) DCHS1 chr11p15.4
1553105_s_at Hs.412597 desmoglein 2 DSG2 chr18q12.1
206710_s_at Hs.213394 erythrocyte membrane protein band 4.1-like 3 EPB41L3 chr18p11.32
215664_s_at Hs.654492 EPH receptor A5 EPHA5 chr4q13.1
206795_at Hs.42502 coagulation factor II (thrombin) receptor-like 2 F2RL2 chr5q13
203184_at Hs.519294 fibrillin 2 (congenital contractural arachnodactyly) FBN2 chr5q23-q31
1565717_s_at Hs.513522 fusion (involved in t(12;16) in malignant liposarcoma) FUS chr16p11.2
208025_s_at Hs.505924 high mobility group AT-hook 2 HMGA2 chr12q15
203819_s_at Hs.700696 insulin-like growth factor 2 mRNA binding protein 3 IGF2BP3 chr7p11
1554757_a_at Hs.709221 inositol polyphosphate-5-phosphatase, 40kDa INPP5A chr10q26.3
213496_at Hs.13245 plasticity related gene 1 LPPR4 chr1p21.2
206163_at Hs.584776 mab-21-like 1 (C. elegans) MAB21L1 chr13q13
210302_s_at Hs.584852 mab-21-like 2 (C. elegans) MAB21L2 chr4q31
205347_s_at Hs.56145 thymosin-like 8 TMSL8 chrXq21.33-q22.3
220615_s_at Hs.298851 male sterility domain containing 1 MLSTD1 chr12p11.22
213067_at Hs.16355 myosin, heavy chain 10, non-muscle MYH10 chr17p13
237206_at Hs.567641 myocardin MYOCD chr17p11.2
227971_at Hs.209527 Nik related kinase NRK chrXq22.3
219978_s_at Hs.615092 nucleolar and spindle associated protein 1 NUSAP1 chr15q15.1
228635_at Hs.192859 protocadherin 10 PCDH10 chr4q28.3
205534_at Hs.479439 protocadherin 7 PCDH7 chr4p15
205501_at Hs.584856 phosphodiesterase 10A PDE10A chr6q26
212092_at Hs.147492 paternally expressed 10 PEG10 chr7q21
204285_s_at Hs.96 phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 chr18q21.32
235874_at Hs.98381 protease, serine, 35 PRSS35 chr6q14.2
1554997_a_at Hs.196384 prostaglandin-endoperoxide synthase 2 PTGS2 chr1q25.2-q25.3
211737_x_at Hs.371249 pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) PTN chr7q33-q34
1555233_at Hs.656339 ras homolog gene family, member J RHOJ chr14q23.2
203186_s_at Hs.654444 S100 calcium binding protein A4 *S100A4 chr1q21
210432_s_at Hs.435274 sodium channel, voltage-gated, type III, alpha subunit SCN3A chr2q24
203626_s_at Hs.23348 S-phase kinase-associated protein 2 (p45) SKP2 chr5p13
207053_at Hs.31961 solute carrier family 8 (sodium/calcium exchanger), member 1 SLC8A1 chr2p23-p22
204913_s_at Hs.432638 SRY (sex determining region Y)-box 11 *SOX11 chr2p25
227705_at Hs.21861 transcription elongation factor A (SII)-like 7 TCEAL7 chrXq22.1
223557_s_at Hs.144513 transmembrane protein with EGF-like and two follistatin-like domains 2 TMEFF2 chr2q32.3
210654_at Hs.213467 tumor necrosis factor receptor superfamily, member 10d, decoy TNFRSF10D chr8p21
219937_at Hs.199814 thyrotropin-releasing hormone degrading enzyme TRHDE chr12q15-q21
219778_at Hs.431009 zinc finger protein, multitype 2 ZFPM2 chr8q23
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gating the genes shared by ESCs and fetal MSCs, as well by
checking the possible outcomes of the preferred ESC gene
patterns in fetal MSCs. A total of 191 probe sets showed
increased levels of both cell types when compared with adult
MSCs (Fig. 1D). To gain more insights into the functional
consequences of differential gene expression and to provide
quantitative evidence, signature genes were searched for in the
Gene Ontology (GO) database [26] in order to find statisticallyoverrepresented functional groups within the gene lists.
DAVID 6.7, a web-based tool, and the graph theory evidence-
based method for agglomerating gene/protein identifiers [22],
were applied to this task. A p-value was assigned to each
category based on the EASE co-occurrence scoring system,
a Fisher’s exact-based method that identifies functional
categories that are overrepresented in a gene list [22]. Given
that the whole human transcriptome was represented in the
microarray that was applied, this analysis was not biased
Table 2
Top 50 known genes in adult MSCs.
Probe Set ID UniGene ID Gene Title Gene Symbol Location
214454_at Hs.591725 ADAM metallopeptidase with thrombospondin type 1 motif, 2 ADAMTS2 chr5qter
202888_s_at Hs.1239 alanyl (membrane) aminopeptidase (CD13, p150) ANPEP chr15q25-q26
230925_at Hs.310421 amyloid beta (A4) precursor protein-binding, family B,
member 1 interacting protein
APBB1IP chr10p12.1
212884_x_at Hs.654439 apolipoprotein E APOE chr19q13.2
213429_at Hs.158745 bicaudal C homolog 1 (Drosophila) BICC1 chr10q21.1
224414_s_at Hs.200242 caspase recruitment domain family, member 6 CARD6 chr5p13.1
224794_s_at Hs.495230 cerebral endothelial cell adhesion molecule CERCAM chr9q34.11
205713_s_at Hs.1584 cartilage oligomeric matrix protein COMP chr19p13.1
201200_at Hs.5710 cellular repressor of E1A-stimulated genes 1 CREG1 chr1q24
206315_at Hs.114948 cytokine receptor-like factor 1 CRLF1 chr19p12
204971_at Hs.518198 cystatin A (stefin A) CSTA chr3q21
226911_at Hs.20103 EGF-like, fibronectin type III and laminin G domains EGFLAM chr5p13.2-p13.1
200878_at Hs.468410 endothelial PAS domain protein 1 EPAS1 chr2p21-p16
205756_s_at Hs.654450 coagulation factor VIII, procoagulant component (hemophilia A) F8 chrXq28
205782_at Hs.567268 fibroblast growth factor 7 (keratinocyte growth factor) FGF7 chr15q15-q21.1
214702_at Hs.203717 fibronectin 1 FN1 chr2q34
226930_at Hs.520525 fibronectin type III domain containing 1 FNDC1 chr6q25




216526_x_at Hs.549053 major histocompatibility complex, class I, B *HLA-B chr6p21.3
208812_x_at Hs.654404 major histocompatibility complex, class I, C *HLA-C chr6p21.3
209581_at Hs.502775 HRAS-like suppressor 3 HRASLS3 chr11q12.3-q13.1
213620_s_at Hs.431460 intercellular adhesion molecule 2 ICAM2 chr17q23-q25
229638_at Hs.499205 iroquois homeobox 3 IRX3 chr16q12.2
202803_s_at Hs.375957 integrin, beta 2 (complement component 3 receptor
3 and 4 subunit)
ITGB2 chr21q22.3
1557080_s_at Hs.696554 integrin, beta-like 1 (with EGF-like repeat domains) ITGBL1 chr13q33
212192_at Hs.644125 potassium channel tetramerisation domain containing 12 KCTD12 chr13q22.3
231031_at Hs.536967 keratinocyte growth factor-like protein 2 KGFLP2 chr9p12
203543_s_at Hs.150557 Kruppel-like factor 9 KLF9 chr9q13
201721_s_at Hs.371021 lysosomal associated multispanning membrane protein 5 LAPTM5 chr1p34
200923_at Hs.514535 lectin, galactoside-binding, soluble, 3 binding protein LGALS3BP chr17q25
206483_at Hs.591865 leucine rich repeat containing 6 LRRC6 chr8q24.22
206584_at Hs.660766 lymphocyte antigen 96 LY96 chr8q21.11
207565_s_at Hs.101840 major histocompatibility complex, class I-related *MR1 chr1q25.3
37005_at Hs.466662 neuroblastoma, suppression of tumorigenicity 1 NBL1 chr1p36.13-p36.11
200632_s_at Hs.372914 N-myc downstream regulated gene 1 NDRG1 chr8q24.3
215870_s_at Hs.319438 phospholipase A2, group V PLA2G5 chr1p36-p34
224506_s_at Hs.134292 phosphatidic acid phosphatase type 2 domain containing 3 PPAPDC3 chr9q34.13
211663_x_at Hs.446429 prostaglandin D2 synthase 21kDa (brain) PTGDS chr9q34.2-q34.3
221840_at Hs.127022 protein tyrosine phosphatase, receptor type, E PTPRE chr10q26
211600_at Hs.160871 protein tyrosine phosphatase, receptor type, O PTPRO chr12p13.3-p13.2j12p13-p12
225188_at Hs.471162 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 RAPH1 chr2q33
200986_at Hs.384598 serpin peptidase inhibitor, clade G (C1 inhibitor), member 1,
(angioedema, hereditary)
SERPING1 chr11q12-q13.1
222784_at Hs.497349 SPARC related modular calcium binding 1 SMOC1 chr14q24.2
201150_s_at Hs.701968 TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy,
pseudoinflammatory)
TIMP3 chr22q12.1-q13.2j22q12.3
213293_s_at Hs.501778 tripartite motif-containing 22 TRIM22 chr11p15
202546_at Hs.714302 vesicle-associated membrane protein 8 (endobrevin) VAMP8 chr2p12-p11.2
204619_s_at Hs.695930 versican VCAN chr5q14.3
228617_at Hs.441975 XIAP associated factor 1 XAF1 chr17p13.2
205383_s_at Hs.655108 zinc finger and BTB domain containing 20 ZBTB20 chr3q13.2
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involved in RNA splicing (including DHX9, FUS, HNRNPM,
HNRNPU, SFRS2, SFRS7, and U2AF1; p ¼ 0.0018; genes are
bolded in Fig. 1D), cell proliferation (AOF2, CDC25A,
CSRP2, DKC1, HELLS, KIT, MYH10, SKP2, SOX11, andTACC2; p ¼ 0.011), and the interphase of the mitotic cell
cycle (CDC123, CDC25A, CHEK1, RHOU, and SKP2;
p ¼ 0.011). These results correlate with the concept that fetal
MSCs have a more multipotent and grow faster than adult
MSCs [16e18].
Fig. 2. Altered functional modules of different MSCs. (A) KEGG pathways that are significantly enriched in each of the MSCs. The number of genes, their
percentages in terms of the total number of genes, and the p-values for pathways that are significantly overrepresented ( p < 0.05) are listed. (B-C) Gene set
enrichment analysis according to the Gene Ontology (GO) classification. Probe sets that are unique in adult or fetal MSCs were searched for in the GO database
using the DAVID 6.7 interface. The number of genes, gene symbols, their percentages, and p-values for each category that shows significance ( p < 0.05) and are
enriched in either adult (B) or fetal (C) MSCs are listed.
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a framework for the interpretation of MSC biologyTo provide a more comprehensive understanding of fetal
and adult MSCs, we also analyzed the enhanced canonical
pathways of each subtype. The genes of the Wnt and mTOR
pathways were enriched in fetal MSCs, while genes associated
with the GnRH signaling pathway were enriched in the adult
stem cells (Fig. 2A). Cell cycle genes were overexpressed in
the fetal MSCs, correlating with their faster proliferation
capacities [16]. On the other hand, antigen processing and
presentation were more active in the adult stem cells (Fig. 2A).
We further applied the GO database to find enriched
biological activities in each type of cell. Adult MSCs signifi-
cantly overexpressed the genes involved in antigen processing
and the presentation of MHC class I peptide antigens
( p ¼ 0.0000248; Fig. 2B), which is consistent with the results
of the KEGG analysis (Fig. 2A). Five BM-MSC genes
(HLA-B, HLA-C, HLA-E, MR1, and B2M) are in this cate-
gory (Fig. 2B), suggesting that fetal MSCs are less immuno-
genic and may induce less allograft rejection. On the other
hand, adult MSCs also overexpressed cell adhesion genes
( p ¼ 0.000341; Fig. 2B), implying that they are less motile.
In contrast, the principal functions of the upregulated genes
in fetal MSCs include those related to RNA splicing, cell
proliferation, the mitotic cell cycle, and DNA replication and
repair (Fig. 2C). The differential splicing genes expressed in
different MSCs indicate that alternative RNA splicing may
occur in MSCs, thereby influencing their biological activities.
Genes involved in in utero embryonic development, leukocyte
differentiation, vasculogenesis, and neurogenesis are more
abundant in fetal MSCs (Fig. 2C), correlating with the aboveFig. 3. Functional genetic network analysis reveals microRNA targets enriched
products) and edges (biological relationships between nodes) that were mapped usi
indicates the degree of upregulation. MicroRNAs are highlighted.observations that these MSCs are more primitive, more similar
to ESC, and, therefore, may hold multipotent differentiation
abilities. Wnt receptor signaling, Ras protein signaling, and
MAPKKK pathway genes are enriched in fetal MSCs and may,
therefore, be responsible for their active proliferation and
diverse differentiation capabilities (Fig. 2C). The genes involved
in the cell cycle, Wnt pathway, and RNA splicing are illustrated
in Supplementary Files 1e4, which are available online.MSC genetic networksThe gene list outlined above gave us preliminary insights
into the functional consequences of the detected differential
gene expression. An increasing amount of evidence shows that
genes do not act as individuals but are collaborative in genetic
networks. To better understand how the genes that are enriched
in different stem cells are related and, most importantly, how
those interactions may be related to cellular functions, we
performed a genetic network analysis to indentify the signa-
ture genes. Filtrated probe sets were input into the IPA soft-
ware to construct network modules. For the fetal MSCs,
a major network consisting of 547 genes was identified (not
shown). Again, genes involved in cell cycle development,
RNA posttranscriptional modification (including RNA
splicing), DNA replication, recombination, and repair were
found in this major network. Interestingly, we found that the
targets of several microRNAs, including miR-124 (Fig. 3A),
miR-1 (Fig. 3B), miR-199a1, miR-17, and miR-181b2
(Fig. 3C), were enriched in the fetal MSCs, suggesting the
reduced expression of these miRNAs in fetal MSCs. Similar
miRNA modules could not be found in the adult MSCs (not
shown).with fetal MSCs. These networks are graphically displayed as nodes (gene
ng the Ingenuity Pathway Analysis (IPA) tool. The intensity of the node color
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possible source of UCB MSCsNow that we have groups of genes that can be used to
represent the two MSCs at the genomic level, the next issue we
addressed was which MSCs are more similar to the UCB-
derived MSCs, i.e., the possible origin of UCB MSCs. We
answered this by including UCB MSCs in a PCA analysis and
calculated the group distances between UCB MSCs, fetal
MSCs, and adult MSCs. As shown in Fig. 4A, clearly the UCB
MSCs have the closest relationship with the fetal MSCs. This
impression was verified by average linkage distance analysis
(Fig. 4B). A heat map based on the fetal and adult MSC
signature genes showed common gene expression patterns
between UCB MSCs and fetal MSCs (Fig. 4C). These two
MSC subtypes also shared more common genes with the ESCs
when compared with the adult MSCs (Fig. 4C).Fig. 4. Relationships between UCB MSCs, fetal MSCs, and adult MSCs. (A) A PC
mPB: maternal PBMC. (B) Average linkage Euclidean distances between MSCs. (C
groups.Novel positive selection biomarkers used to isolate
circulating fetal MSCs from maternal bloodIt has been shown that fetal MSCs hold the potential for
noninvasive prenatal diagnosis [25]. Isolating fetal MSCs from
posttermination maternal blood using positive selection strat-
egies relies largely on the identification of the novel surface
antigens that are present on the circulating human fetal MSCs
but not on maternal cells, including peripheral blood mono-
nuclear cells (PBMC) and the maternal adult MSCs. We
compared the transcriptome profiles of fetal MSCs and paired
maternal PBMC and then searched for genes that are rarely
expressed in adult MSCs. A total of 90 genes were found to fit
the above criteria (Fig. 5A). Four cell membrane proteins were
found to be unique in the fetal MSCs, including CPE, FZD2,
ADAM23, and PVR (Fig. 5B). Among these, the expression of
CPE (carboxypeptidase E) has recently been verified byA plot using genes that are differentially expressed in adult and fetal MSCs.
) A heat map showing the gene distribution patterns among the different MSC
Fig. 5. Potential surface antigens for noninvasive prenatal diagnosis. A Venn diagram showing 90 unique genes in fetal MSCs. (B) Scatter plots illustrating cell-
surface transcripts that are expressed in fetal MSCs but not in maternal PBMCs (mPBMC) or adult MSCs. (C) Genes not in mPBMC, but commonly expressed by
both fetal and adult MSCs.
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maternal PBMC [25]. Other surface markers described by
Gotherstrom et al were not differentially expressed in the adult
and fetal MSCs (Fig. 5C).
Discussion
MSCs have attracted a great deal of attention due to their
unique stemness and differential abilities, as well as their
potential uses in regenerative medicine. Much progress has
been made in MSC research, yet the clinical application of
these cells is stymied by an insufficient understanding of how
to functionally integrate their complex, interactive genetic
processes. Further characterization of stem cells via a global,
genomics-based approach will be critical to both better
understand the molecular events involved in the properties of
stem cells and how to utilize these cells. It is now clear that the
functional differences between MSC populations could be
a function of their transcriptomes.
So far, the origin of UCB MSCs is still subject to debate.
Gene signature analyses have showed that UCB MSCs have
a distinct gene expression pattern and biological activities and
are, therefore, different from MSCs that come from an adult
origin [2,14]. Comparative gene expression profiling of MSCs
from paired umbilical cord units have also revealed thatumbilical cord MSCs are different from UCB MSCs [27]. It
has been postulated that both fetal hematopoietic cells and
MSCs travel, via the fetal blood, from early fetal hematopoi-
etic sites to newly formed bone marrow [2,13]. It is, therefore,
possible that fetal MSCs will circulate in fetal blood and then
enter the umbilical cord to become UCB MSCs. The confir-
mation of transplacental trafficking of other fetal cells via cord
blood into the maternal circulation, albeit at a low frequency,
further strengthens this hypothesis: various fetal cell types,
such as trophoblasts, leukocytes, nucleated erythrocytes,
platelets, and hematopoietic progenitors, could be isolated
from maternal blood [28e30]. Since the origin of MSCs will
determine their functional characteristics, and since hemato-
poietic stem cells (HSCs) and MSCs have been clinically used
in cell-based therapies, the characteristics and classification of
UCB MSCs will provide further insights and benefit the
selection of cell sources.
Fetal MSCs have also been observed in maternal circulation
[31]. The transplacental trafficking of fetal MSCs represents
a promising candidate for noninvasive prenatal diagnosis.
However, fetal MSCs are rarely present in posttermination
maternal blood (w1 cell per 106-7 maternal PBMCs [28,29]).
The identification of the surface antigens specific to fetal
MSCs will benefit from the development of novel and
noninvasive prenatal diagnosis methods based on positive
456 S.-L. Weng et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 447e457selection strategies. A recent genomics study compared the
gene expression profiles of fetal MSCs and maternal PBMCs
(mPBMCs) as possible surface antigens for noninvasive
prenatal diagnosis [25]. Eighteen unique surface proteins,
including CPE and OSMR, were filtrated from the array data
and confirmed by RT-PCR and immunocytochemistry [25].
However, it has also been demonstrated that adult MSCs can
be mobilized into peripheral blood [32,33]. To exclude the
contamination of maternal MSCs during positive purification,
marker identification of fetal MSCs in maternal blood could be
improved by further comparing fetal MSC genetic profiles
with those of adult MSCs.
In summary, our findings shed light on common myths
surrounding different types of MSCs, provide evidence of the
underlying mechanisms, and contribute to the development of
cell-based therapies. Studying the genes or pathways that are
differentially expressed in various MSCs may eventually
decipher the mechanisms of stemness, neurogenesis, angio-
genesis, and osteogenesis. Thus, this study provides novel
strategies for further functional or mechanistic studies on stem
cells. The approaches taken here can also serve as a model for
the comparison of other complex biological systems or the
functions of a given gene.
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